Search Constraints
« Previous |
21 - 40 of 53
|
Next »
Search Results
Select an image to start the slideshow
Novel approaches targeting phosphoinositide 3-kinase delta
1 of 20
Studies towards the synthesis and labelling of bioactive peptides
2 of 20
Novel C-C bond formation strategies for access to secondary and tertiary amides enabled by new synthetic technologies
3 of 20
Synthesis and optimisation of novel molecules to probe epigenetic mechanisms with applications in the treatment of inflammatory disorders
4 of 20
A medicinal chemistry approach towards brodomain epigenetic modulators
5 of 20
The development and evaluation of a method for the quantitative determination of a monoclonal antibody using capillary electrophoresis-high resolution mass spectrometry
6 of 20
New methods for the synthesis of pharmaceutical azacycles
7 of 20
Hi-JAK-ing the ubiquitin system : the design and physicochemical optimisation of JAK PROTACs
8 of 20
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
9 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
10 of 20
Targeted protein degradation as a new approach to drug discovery
11 of 20
New chemical approaches for the development of targeted protein degradation
12 of 20
The development of chemo- and regioselective reactions of boron systems
13 of 20
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
14 of 20
The design and synthesis of novel epigenetic modulators
15 of 20
Preclinical development of a treatment for systemic lupus erythematosus
16 of 20
The use of contemporary chemoproteomic techniques in antimalarial target identification
17 of 20
Investigations of the synthesis and properties of romodomain and extra-terminal domain proteolysis targeting chimeras
18 of 20
New hydrogen atom transfer methodologies for synthesis
19 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
20 of 20